Frontlight ResearchEarly access
Trial site
Japanese Red Cross Nagoya Daini Hospital
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation2 trials
- Diffuse large B-cell lymphoma2 trials
- Myeloproliferative neoplasms2 trials
- Follicular lymphoma1 trial
- Multiple myeloma1 trial
- Prostate cancer1 trial
- Phase
- Phase 36 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Terminated2 trials
- Lead sponsor
- Incyte Corporation3 trials
- Janssen Research & Development, LLC2 trials
- Eli Lilly and Company1 trial
- Genmab1 trial
- Incyte Biosciences Japan GK1 trial
- and 1 more
Running trials
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Terminated
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026